Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Environmental Exposure | 4 | 2014 | 216 | 0.550 |
Why?
|
Agriculture | 2 | 2014 | 56 | 0.520 |
Why?
|
Chemical Hazard Release | 1 | 2015 | 2 | 0.510 |
Why?
|
Civil Defense | 1 | 2015 | 11 | 0.500 |
Why?
|
Environmental Health | 1 | 2015 | 41 | 0.490 |
Why?
|
Disaster Planning | 1 | 2015 | 52 | 0.470 |
Why?
|
Sunlight | 1 | 2014 | 47 | 0.460 |
Why?
|
Health Surveys | 2 | 2015 | 373 | 0.450 |
Why?
|
Health Behavior | 2 | 2016 | 537 | 0.440 |
Why?
|
Communication | 1 | 2015 | 180 | 0.440 |
Why?
|
Carbon Monoxide Poisoning | 1 | 2012 | 2 | 0.420 |
Why?
|
Arsenic | 1 | 2014 | 144 | 0.400 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2014 | 1039 | 0.390 |
Why?
|
Disasters | 1 | 2012 | 65 | 0.380 |
Why?
|
Cyclonic Storms | 1 | 2012 | 64 | 0.380 |
Why?
|
Pesticides | 5 | 2012 | 52 | 0.370 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2016 | 643 | 0.350 |
Why?
|
Mercury Poisoning | 1 | 2009 | 5 | 0.340 |
Why?
|
Glutathione | 1 | 2009 | 179 | 0.310 |
Why?
|
Florida | 5 | 2019 | 410 | 0.290 |
Why?
|
Occupational Exposure | 4 | 2019 | 79 | 0.240 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2019 | 864 | 0.190 |
Why?
|
Heat Stress Disorders | 1 | 2019 | 7 | 0.170 |
Why?
|
Family Health | 1 | 2016 | 56 | 0.130 |
Why?
|
Attitude to Health | 2 | 2016 | 325 | 0.120 |
Why?
|
Protective Clothing | 1 | 2014 | 6 | 0.120 |
Why?
|
Sunscreening Agents | 1 | 2014 | 9 | 0.120 |
Why?
|
Cooperative Behavior | 1 | 2015 | 219 | 0.110 |
Why?
|
Respiratory Sounds | 1 | 2012 | 11 | 0.110 |
Why?
|
Cough | 1 | 2012 | 18 | 0.110 |
Why?
|
Nitric Oxide Synthase | 2 | 2003 | 128 | 0.100 |
Why?
|
Humans | 11 | 2019 | 37093 | 0.100 |
Why?
|
Public Health | 1 | 2015 | 372 | 0.090 |
Why?
|
Residence Characteristics | 1 | 2012 | 322 | 0.090 |
Why?
|
Mercuric Chloride | 1 | 2009 | 2 | 0.090 |
Why?
|
Buthionine Sulfoximine | 1 | 2009 | 12 | 0.090 |
Why?
|
Glutamate-Cysteine Ligase | 1 | 2009 | 17 | 0.090 |
Why?
|
Cytoprotection | 1 | 2009 | 36 | 0.080 |
Why?
|
Sulfhydryl Compounds | 1 | 2009 | 47 | 0.080 |
Why?
|
Acetylcysteine | 1 | 2009 | 62 | 0.080 |
Why?
|
Naled | 1 | 2008 | 1 | 0.080 |
Why?
|
Neuroblastoma | 1 | 2009 | 129 | 0.080 |
Why?
|
Mosquito Control | 1 | 2008 | 14 | 0.080 |
Why?
|
Culicidae | 1 | 2008 | 24 | 0.080 |
Why?
|
Cell Survival | 2 | 2009 | 864 | 0.080 |
Why?
|
Male | 8 | 2019 | 20025 | 0.080 |
Why?
|
Female | 8 | 2019 | 20969 | 0.070 |
Why?
|
Product Packaging | 1 | 2007 | 6 | 0.070 |
Why?
|
Congenital Abnormalities | 1 | 2007 | 21 | 0.070 |
Why?
|
Emergency Medical Technicians | 1 | 2006 | 7 | 0.070 |
Why?
|
Police | 1 | 2006 | 17 | 0.070 |
Why?
|
Commerce | 1 | 2007 | 87 | 0.070 |
Why?
|
Glioma | 2 | 2003 | 79 | 0.070 |
Why?
|
Schools | 1 | 2005 | 260 | 0.060 |
Why?
|
Monoamine Oxidase | 1 | 2003 | 34 | 0.060 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 2231 | 0.050 |
Why?
|
Neurotransmitter Agents | 1 | 2002 | 63 | 0.050 |
Why?
|
Neuroglia | 1 | 2002 | 124 | 0.050 |
Why?
|
Dopamine | 1 | 2002 | 245 | 0.050 |
Why?
|
Occupational Health | 1 | 2019 | 29 | 0.040 |
Why?
|
Adult | 5 | 2019 | 11712 | 0.040 |
Why?
|
Transients and Migrants | 1 | 2019 | 39 | 0.040 |
Why?
|
Georgia | 1 | 2019 | 174 | 0.040 |
Why?
|
Hot Temperature | 1 | 2019 | 128 | 0.040 |
Why?
|
Middle Aged | 4 | 2019 | 10129 | 0.040 |
Why?
|
Animals | 4 | 2009 | 15081 | 0.040 |
Why?
|
Mice | 1 | 2009 | 5913 | 0.040 |
Why?
|
Risk Factors | 3 | 2016 | 3562 | 0.040 |
Why?
|
Aged | 2 | 2019 | 6741 | 0.030 |
Why?
|
Acute Disease | 2 | 2007 | 147 | 0.030 |
Why?
|
Genomics | 1 | 2016 | 223 | 0.030 |
Why?
|
Life Style | 1 | 2016 | 308 | 0.030 |
Why?
|
Adolescent | 3 | 2012 | 5363 | 0.030 |
Why?
|
Incidence | 2 | 2007 | 922 | 0.030 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2003 | 115 | 0.030 |
Why?
|
United States | 3 | 2007 | 4223 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2003 | 502 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 2721 | 0.020 |
Why?
|
Child | 2 | 2012 | 3131 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2012 | 242 | 0.020 |
Why?
|
Infant | 1 | 2012 | 1046 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 1418 | 0.020 |
Why?
|
Prevalence | 1 | 2012 | 1455 | 0.020 |
Why?
|
Insecticides | 1 | 2008 | 51 | 0.020 |
Why?
|
North Carolina | 1 | 2007 | 104 | 0.020 |
Why?
|
Food Contamination | 1 | 2007 | 55 | 0.020 |
Why?
|
Environmental Monitoring | 1 | 2008 | 192 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2007 | 195 | 0.020 |
Why?
|
Poisoning | 1 | 2005 | 12 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 4268 | 0.020 |
Why?
|
Population Surveillance | 1 | 2007 | 238 | 0.020 |
Why?
|
Data Collection | 1 | 2006 | 194 | 0.020 |
Why?
|
Rats | 2 | 2003 | 3483 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2007 | 894 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2006 | 610 | 0.010 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2002 | 9 | 0.010 |
Why?
|
Imines | 1 | 2002 | 10 | 0.010 |
Why?
|
Nitrites | 1 | 2002 | 46 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2002 | 52 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2003 | 220 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2003 | 550 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 859 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 433 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2002 | 461 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2002 | 578 | 0.010 |
Why?
|
Inflammation | 1 | 2003 | 618 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2002 | 1207 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2002 | 1015 | 0.010 |
Why?
|